Minimally Invasive Coronary Artery Bypass Grafting for Multivessel Coronary Artery Disease: A Systematic Review.
Davorin SefMyat Soe ThetShahrul Amry HashimKeita KikuchiPublished in: Innovations (Philadelphia, Pa.) (2024)
MICS CABG appears to be a safe method in well-selected patients with multivessel CAD. This approach is concentrated at dedicated centers, and there is no widespread application, although it has potential to be widely applicable as an alternative for surgical revascularization. However, large randomized controlled studies with longer follow-up are still required to compare the outcomes with conventional CABG and other revascularization strategies.
Keyphrases
- coronary artery bypass grafting
- coronary artery disease
- percutaneous coronary intervention
- minimally invasive
- cardiovascular events
- st segment elevation myocardial infarction
- double blind
- st elevation myocardial infarction
- open label
- placebo controlled
- phase iii
- phase ii
- aortic stenosis
- coronary artery bypass
- acute coronary syndrome
- robot assisted
- heart failure
- type diabetes
- study protocol
- clinical trial
- risk assessment
- metabolic syndrome
- skeletal muscle
- glycemic control